Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the

Sachiko Ito1, Makoto Sawada, Masataka Haneda

  • 1Department of Basic Gerontology, National Institute for Longevity Sciences, 36-3 Gengo, Morioka-cho, Obu, Aichi 474-8522, Japan.

FEBS Letters
|March 29, 2005
PubMed

Insights

Alzheimer's disease amyloid-beta peptides stimulate microglial proliferation by increasing macrophage colony-stimulating factor (M-CSF) expression. This occurs through the phosphatidylinositol 3-kinase/Akt/NF-kappaB signaling pathway.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) is marked by amyloid-beta (Abeta) plaques and microglial activation.
  • Microglia play a crucial role in AD pathogenesis and neuroinflammation.

Purpose of the Study:

  • To investigate the mechanism by which Abeta peptides induce microglial proliferation.
  • To identify the specific signaling pathways involved in Abeta-mediated M-CSF expression.

Main Methods:

  • Utilized a mouse microglial cell line (Ra2).
  • Assessed M-CSF mRNA expression following Abeta treatment.
  • Employed kinase inhibitors (PI3-kinase inhibitor LY294002, Src inhibitor PP1, Akt inhibitor).
  • Performed electrophoretic mobility shift assays (EMSA) to evaluate NF-kappaB DNA binding activity.

Main Results:

  • Abeta treatment increased M-CSF mRNA expression in Ra2 cells.
  • Inhibitors of PI3-kinase, Src family kinases, and Akt blocked Abeta-induced M-CSF expression.
  • Abeta enhanced NF-kappaB binding to the M-CSF promoter, an effect abolished by LY294002.
  • The PI3-kinase/Akt/NF-kappaB pathway mediates Abeta-induced M-CSF expression.

Conclusions:

  • Abeta peptides stimulate microglial proliferation via increased M-CSF expression.
  • The signaling cascade involves PI3-kinase, Akt, and NF-kappaB activation.
  • This pathway represents a potential therapeutic target for Alzheimer's disease.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...